Portrait of Buck, Kenneth R.

Buck, Kenneth R.

U.S. Representative CO-4 Republican Party

Congressional stock trade history disclosed under the STOCK Act, as filed.

Disclosed trades
79
Buys / sells
52% / 48%
Last trade
Sep 9, 2021
Last filing
Oct 17, 2021

Latest disclosed trades

Latest 10 of 79
Ticker Type Traded
HP Sell Sep 9, 2021
— Edgewood growth Fund-Retail F Il Buy Dec 4, 2017
— Dodge & Cox Stock Fund F IlINg S Buy Dec 4, 2017
BAC Sell Nov 7, 2017
BP Sell Nov 7, 2017
CSCO Sell Nov 7, 2017
PBF Sell Nov 7, 2017
GSK Sell Nov 7, 2017
LVS Sell Nov 7, 2017
NOK Sell Nov 7, 2017

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.

Buck, Kenneth R. stock trade activity

FilingIQ has indexed 79 congressional stock trade disclosures for Buck, Kenneth R.. The most recent disclosed transaction is dated Sep 9, 2021.

Across the full history, 41 purchases and 38 sales have been disclosed under the STOCK Act.

Top tickers traded by Buck, Kenneth R.

Frequently asked

How many stock trades has Buck, Kenneth R. disclosed?
FilingIQ tracks 79 Periodic Transaction Report disclosures for Buck, Kenneth R., with the most recent dated Sep 9, 2021. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Buck, Kenneth R. a net buyer or net seller?
Across the disclosed trade history, 41 (52%) were purchases and 38 (48%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Buck, Kenneth R. come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.